TEIKO.BIO
Teiko.bio is an immune profiling platform that enables clinicians to make informed decisions around patient response. The company was founded in 2020 and is based in Salt Lake City, Utah.
TEIKO.BIO
Industry:
Biometrics Biotechnology Health Care Health Diagnostics Life Science Medical
Founded:
2020-01-01
Address:
Salt Lake City, Utah, United States
Country:
United States
Website Url:
http://www.teiko.bio
Total Employee:
1+
Status:
Active
Total Funding:
11.64 M USD
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Euro SPF Google Tag Manager WordPress Google Analytics Amazon Global Site Tag Mobile Non Scaleable Content
Similar Organizations
Cabaletta Bio
Cabaletta Bio has adapted clinically-validated and FDA-approved CAR T cell technology to target B cell-mediated autoimmune diseases.
SonALAsense
SonALAsense develops SDT (Sonodynamic Therapy) intended to turn glioblastoma multiforme (GBM) patients into cancer survivors.
Verismo Therapeutics
Verismo Therapeutics develops novel chimeric antigen receptors (CARs) that enhance T-cell-based cellular immunotherapy for cancer.
VISKA Bio
VISKA Bio is an early-stage immunotherapy platform that engages localized immunogenic cell death to treat and prevent cancer.
Current Employees Featured
Daniel Simon Business Advisor @ Teiko.bio
Business Advisor
2021-02-01
Ramji Srinivasan Founder, CEO @ Teiko.bio
Founder, CEO
Matthew Spitzer Scientific Founder @ Teiko.bio
Scientific Founder
Founder
Investors List
Twine Ventures
Twine Ventures investment in Seed Round - Teiko.bio
Altitude Lab
Altitude Lab investment in Seed Round - Teiko.bio
Pathfinder
Pathfinder investment in Series A - Teiko.bio
Civilization Ventures
Civilization Ventures investment in Series A - Teiko.bio
HOF Capital
HOF Capital investment in Series A - Teiko.bio
Alix Ventures
Alix Ventures investment in Series A - Teiko.bio
Darian Shirazi
Darian Shirazi investment in Series A - Teiko.bio
EPIC Ventures
EPIC Ventures investment in Series A - Teiko.bio
Founders Fund
Founders Fund investment in Series A - Teiko.bio
Global Founders Capital
Global Founders Capital investment in Series A - Teiko.bio
Official Site Inspections
http://www.teiko.bio Semrush global rank: 5.86 M Semrush visits lastest month: 1.2 K
- Host name: aacb0a264e514dd48.awsglobalaccelerator.com
- IP address: 99.83.190.102
- Location: Seattle United States
- Latitude: 47.54
- Longitude: -122.3032
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98108
More informations about "Teiko.bio"
About Us - Teiko.bio
Teiko Bio's team is comprised of PhD-trained experts in the field of Immunology and Bioinformatics. Find out more about our cofounders' background & …See details»
Teiko.bio - Crunchbase Company Profile & Funding
Organization. Teiko.bio . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. ... Teiko.bio is an immune …See details»
Teiko.bio 2025 Company Profile: Valuation, Funding
Teiko.bio General Information Description. Developer of an immune profiling platform designed to deliver life-changing therapies. The company's platform …See details»
Teiko.bio - Funding, Financials, Valuation & Investors - Crunchbase
Teiko.bio is an immune profiling platform that enables clinicians to make informed decisions around patient response. New. Resources. Advanced Search. ... How much funding has this …See details»
Teiko Bio: Ramji Srinivasan - Tau Ventures
The fate of a drug requires scientists to make decisions based on a multi-million datapoint dataset with little training. Our platform delivers immediately analyzable datasets—no weeks-long …See details»
Teiko Bio in Salt Lake City, UT - (646) 796-4963 - Company Profile
Teiko Bio is in the Biotechnical Research, Commercial business. View competitors, revenue, employees, website and phone number.See details»
Teiko.bio - Tech Stack, Apps, Patents & Trademarks - Crunchbase
Teiko.bio is an immune profiling platform that enables clinicians to make informed decisions around patient response. New. Resources. Advanced Search. Start Free Trial . Talk With …See details»
Teiko Bio - Altitude Lab
Today, Teiko delivers on its mission by supporting therapy development and informing clinical decision making. The immune system is in our blood. Unlock actionable data tied to real-world …See details»
R&D Internship - Teiko
Our mission is to make immune measurement a reality for clinical trials and patients. If we achieve this mission, we will put 100+ years back on the clock for drug developers, physicians and …See details»
Justin Jarrell, PhD - Vice President Of Business Development at …
Prior to joining Teiko.bio, Justin worked at indee labs from 2018 to 2021 as Vice President Research, Director of Research, Senior Scientist, and Scientist. In this role, they led a growing …See details»
Altitude Lab
Feb 28, 2024 In addition to growing attendance, Altitude Lab's portfolio companies and alumni, including Known Medicine (acquired by Pathos Inc.), Teiko Bio, Aumenta Bio, and Peel …See details»
Teiko - YouTube
Our mission is to make immune measurement a reality for clinical trials and patients. You wouldn’t run an Ozempic trial without a weight scale; and our aim i...See details»
FAQs - Teiko.bio
At Teiko Bio, we’ve worked with a wide range of sample types across human, mouse, and non-human primates. This includes PBMCs, whole blood, bone marrow aspirate, TILs, cell therapy …See details»
Activity · Ben-Driggs/Teiko.Bio_Exam_Ben_Driggs - GitHub
Technical Exam for an Engineering Internship at Teiko.Bio. - Activity · Ben-Driggs/Teiko.Bio_Exam_Ben_DriggsSee details»
Disrupting CD38-driven T cell dysfunction restores ... - bioRxiv
Mar 26, 2024 A central problem in cancer immunotherapy with immune checkpoint blockade (ICB) is the development of resistance, which affects 50% of patients with metastatic …See details»
TokuFocus: Announcing “focused” panels for spectral flow and …
Jan 24, 2025 Teiko’s cytometry services allow you to measure 146 – 840 of populations, a 6-17X increase compared to conventional 13-marker flow cytometry panels. ... These features will be …See details»
WuXi Biologics Named to CDP Water Security "A List" for Second ...
1 day ago WuXi Biologics ("WuXi Bio") (2269.HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), today announced it has been …See details»
Teiko releases Yokozuna: Absolute Cell Counts, Unified “Immune …
Mar 5, 2025 View absolute cell counts for all gated populations and functional subsets on app.teiko.bio. Access boxplots, stacked bars, and other visualizations showing absolute cell …See details»
How-to: Export your cytometry data - Teiko
This is a step-by-step guide to download a demo dataset from Teiko’s immune profiling assay. The dataset is from a Phase I/II clinical trial evaluating responders versus non-responders in …See details»
Unsupervised clustering reveals cell type missed by eye in
In this poster, presented at the SITC Spring Scientific 2025, we used unsupervised clustering to analyze a 29M cell cytometry dataset to identify immune cell populations and subsets that …See details»